These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24998573)

  • 21. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
    Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
    Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of PICT1 in patients of hepatocellular carcinoma with wild-type TP53.
    Ishibashi M; Kogo R; Shibata K; Ueo H; Uchi R; Matsumura T; Takano Y; Sawada G; Takahashi Y; Mima K; Kurashige J; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Suzuki A; Wakabayashi G; Mori M; Mimori K
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S537-44. PubMed ID: 23532381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression.
    Heo MJ; Kim YM; Koo JH; Yang YM; An J; Lee SK; Lee SJ; Kim KM; Park JW; Kim SG
    Oncotarget; 2014 May; 5(9):2792-806. PubMed ID: 24798342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.
    Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY
    Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TREM-1, an inflammatory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression.
    Duan M; Wang ZC; Wang XY; Shi JY; Yang LX; Ding ZB; Gao Q; Zhou J; Fan J
    Ann Surg Oncol; 2015 Sep; 22(9):3121-9. PubMed ID: 25465376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-384 regulated IRS1 expression and suppressed cell proliferation of human hepatocellular carcinoma.
    Lai YY; Shen F; Cai WS; Chen JW; Feng JH; Cao J; Xiao HQ; Zhu GH; Xu B
    Tumour Biol; 2016 Oct; 37(10):14165-14171. PubMed ID: 27542674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RIP1 upregulation promoted tumor progression by activating AKT/Bcl-2/BAX signaling and predicted poor postsurgical prognosis in HCC.
    Wang C; Yao B; Xu M; Zheng X
    Tumour Biol; 2016 Nov; 37(11):15305-15313. PubMed ID: 27699664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-144 suppresses the proliferation and metastasis of hepatocellular carcinoma by targeting E2F3.
    Cao T; Li H; Hu Y; Ma D; Cai X
    Tumour Biol; 2014 Nov; 35(11):10759-64. PubMed ID: 25073510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3.
    Xu L; Dai W; Li J; He L; Wang F; Xia Y; Chen K; Li S; Liu T; Lu J; Zhou Y; Wang Y; Guo C
    Oncotarget; 2016 May; 7(18):26027-41. PubMed ID: 27029030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
    Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
    Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic effect of MiR-146a mimic and cetuximab on hepatocellular carcinoma cells.
    Huang S; He R; Rong M; Dang Y; Chen G
    Biomed Res Int; 2014; 2014():384121. PubMed ID: 24895573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-362-5p promotes tumor growth and metastasis by targeting CYLD in hepatocellular carcinoma.
    Ni F; Zhao H; Cui H; Wu Z; Chen L; Hu Z; Guo C; Liu Y; Chen Z; Wang X; Chen D; Wei H; Wang S
    Cancer Lett; 2015 Jan; 356(2 Pt B):809-18. PubMed ID: 25449782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
    Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
    Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L; Chu F; Cao Y; Shao J; Wang F
    Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
    Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P
    Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.
    Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-217 suppresses proliferation, migration, and invasion promoting apoptosis via targeting MTDH in hepatocellular carcinoma.
    Zhang M; Li M; Li N; Zhang Z; Liu N; Han X; Liu Q; Liao C
    Oncol Rep; 2017 Mar; 37(3):1772-1778. PubMed ID: 28184926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.